Siegfried Holding
Dr. Christian von Falkenhausen currently serves as the Chief Strategy Officer at Siegfried since February 2025. Prior to this role, Dr. von Falkenhausen was the Head of Strategy and M&A at Axplora from August 2020 to January 2025, and a Consultant at Boston Consulting Group from March 2018 to August 2020, progressing from Junior Consultant. Earlier experience includes the role of Research Associate at BASF from November 2014 to December 2017 and serving as a Graduate Research and Teaching Assistant at Universität Mannheim during the same period. Dr. von Falkenhausen holds a PhD in Supply Chain Management from the University of Mannheim (2014-2017), an MS in Management from the University of Mannheim (2011-2014), and a BA in Business Economics from the University of Exeter (2008-2011).
This person is not in any teams
This person is not in any offices
Siegfried Holding
1 followers
Siegfried Holding AG is a Switzerland-based life sciences company and active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States and China.